You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Research & Development
23 July 2026 - Diagnostic specialist Eurofins Viracor, a subsidiary of product testing provider Eurofins Scientific (Euronext Paris:ERF), announced on Wednesday the commercial availability of the BKV ...
23 July 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib), a ROS1 selective inhib...
22 July 2026 - Australian pharmaceutical company Hugel Aesthetics announced on Tuesday a major expansion of its US business as part of its long-term growth strategy.The expansion includes the launch o...
21 July 2026 - Kyowa Kirin EMEA, a subsidiary of Japanese pharmaceutical company Kyowa Kirin Co Ltd (TSE:4151), said on Tuesday that the European Commission has approved an expanded indication for Cry...
21 July 2026 - Clinical-stage biopharmaceutical company AbelZeta Pharma Inc announced on Monday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) ha...
17 July 2026 - Swedish biopharmaceutical company Camurus AB (STO:CAMX) said on Friday that the US Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application for CA...
Related Headlines
MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA
FDA grants priority review to Genentech's Gazyva for primary membranous nephropathy
AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy
Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil
European Commission approves Erbitux combination for first-line BRAF V600E-mutant mCRC